Skip to content

Effect of VAPcare in prevention of pneumonia in patient admitted with ventilator

Efficacy and safety of automated continuous antiseptic lavage and suctioning of oral, oro-pharyngeal and subglottic secretions (VAPCare) among ventilated patients in developing ventilator associated pneumonia during hospitalization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021928
Enrollment
420
Registered
2019-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: VAPcare medical device: We will connect the patients in the intervention group to VAPCare medical device with a disposable lumen (VAPLumen) that rides over the CASS ET tube with ports i

Sponsors

Dr D Vimal Bhardwaj
Lead Sponsor
InnAccel Technologies Private Limited
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient aged more than or equal to 18 years, both the genders in the emergency and medical/surgical intensive care units. 2. Requiring artifical ventilation for more than 48 hours 3. Subject or legally authorized representative/patient relative willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.A regular ET tube without continuous aspiration of subglottic secretion port 2. A previous diagnosis of a. Pulmonary tuberculosis b. Bronchopneumonia c. HIV d. Ventricular fibrillation e. Cardiac arrest f. Bleeding disorders/ on oral anticoagulants g. Pregnancy h. Head/ neck/ facial injuries 3. Tracheostomy at the time of admission 4. Patients enrolled for another clinical study

Design outcomes

Primary

MeasureTime frame
Proportion of patients developing ventilator associated pneumonia at the time of extubation or death or discharge against medical advice as defined by CDC, which is a Clinical suspicion of pneumonia in a patient mechanically ventilated for more than 48h and new or changing chest X-ray infiltrate with 2 out of following 3 clinical findings – new onset fever, leukocytosis, and purulent tracheal secretions with/without microbiological diagnosis.Timepoint: more than 48 hours

Secondary

MeasureTime frame
1.Adverse event rate 2.Mortality 3.Time to VAP rate 4.Duration of stay in the ICU/ hospitalization 5.Antibiotic usage 6.Microbiological assay (including oropharyngeal and subglottic secretions) 7.Cost effectiveness analysis 8.Volume of secretion collected in each region Timepoint: more than 48 hours

Countries

India

Contacts

Public ContactDr Arjun Alva

Mazumdar Shaw Medical Center, Narayana Health city

vmlbhardwaj@yahoo.co.in9686124830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026